Sericin coated thin polymeric films reduce keratinocyte proliferation via the mTOR pathway and epidermal inflammation through IL17 signaling in psoriasis rat model.

Pornanong Aramwit, Kamonpan Fongsodsri, Khwanchanok Tuentam, Onrapak Reamtong, Tipparat Thiangtrongjit, Tapanee Kanjanapruthipong, Vamsi K Yadavalli, Sumate Ampawong
Author Information
  1. Pornanong Aramwit: Bioactive Resources for Innovative Clinical Applications Research Unit, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Phayathai Road, Pathumwan, Bangkok, 10330, Thailand.
  2. Kamonpan Fongsodsri: Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok, 10400, Thailand.
  3. Khwanchanok Tuentam: Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok, 10400, Thailand.
  4. Onrapak Reamtong: Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Ratchawithi Road, Ratchathewi, Bangkok, 10400, Thailand.
  5. Tipparat Thiangtrongjit: Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Ratchawithi Road, Ratchathewi, Bangkok, 10400, Thailand.
  6. Tapanee Kanjanapruthipong: Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok, 10400, Thailand.
  7. Vamsi K Yadavalli: Department of Chemical and Life Science Engineering, Virginia Commonwealth University, 601 W Main Street, Richmond, VA, 23284, USA.
  8. Sumate Ampawong: Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok, 10400, Thailand. am_sumate@hotmail.com.

Abstract

Therapeutic treatment forms can play significant roles in resolving psoriatic plaques or promoting wound repair in psoriatic skin. Considering the biocompatibility, mechanical strength, flexibility, and adhesive properties of silk fibroin sheets/films, it is useful to combine them with anti-psoriatic agents and healing stimulants, notably silk sericin. Here, we evaluate the curative properties of sericin-coated thin polymeric films (ScF) fabricated from silk fibroin, using an imiquimod-induced psoriasis rat model. The film biocompatibility and psoriatic wound improvement capacity was assessed. A proteomics study was performed to understand the disease resolving mechanisms. Skin-implantation study exhibited the non-irritation property of ScF films, which alleviate eczema histopathology. Immunohistochemical and gene expression revealed the depletion of β-defensin, caspase-3 and -9, TNF-α, CCL-20, IL-1β, IL-17, TGF-β, and Wnt expressions and S100a14 mRNA level. The proteomics study suggested that ScF diminish keratinocyte proliferation via the mTOR pathway by downregulating mTOR protein, corresponding to the modulation of TNF-α, Wnt, and IL-1β levels, leading to the enhancement of anti-inflammatory environment by IL-17 downregulation. Hematology data demonstrated the safety of using these biomaterials, which provide a potential therapeutic-option for psoriasis treatment due to desirable effects, especially anti-proliferation and anti-inflammation, functioning via the mTOR pathway and control of IL-17 signaling.

References

Acta Derm Venereol. 1974;54(6):465-9 [PMID: 4140662]
Sci Rep. 2020 Oct 19;10(1):17618 [PMID: 33077734]
J Invest Dermatol. 2013 Jun;133(6):1556-64 [PMID: 23314787]
Int J Mol Sci. 2018 Apr 09;19(4): [PMID: 29642540]
Dermatol Ther. 2019 Mar;32(2):e12825 [PMID: 30650216]
Front Immunol. 2021 Feb 12;11:599947 [PMID: 33643287]
Clin Rheumatol. 2014 Dec;33(12):1759-64 [PMID: 24005838]
Nucleic Acids Res. 2000 Jan 1;28(1):27-30 [PMID: 10592173]
J Dermatol Sci. 2022 Jan;105(1):11-17 [PMID: 34973880]
Theranostics. 2020 Jan 1;10(2):741-756 [PMID: 31903148]
Indian J Dermatol. 2014 Jan;59(1):67-70 [PMID: 24470663]
J Dermatol Sci. 2001 Jun;26(2):119-24 [PMID: 11378328]
J Tradit Complement Med. 2021 Jul 01;11(6):587-597 [PMID: 34765523]
Cell Stress Chaperones. 2019 Nov;24(6):1027-1044 [PMID: 31734893]
Nat Protoc. 2011 Sep 22;6(10):1612-31 [PMID: 21959241]
An Bras Dermatol. 2023 Jan-Feb;98(1):68-74 [PMID: 36319514]
Hum Genomics. 2018 May 21;12(1):27 [PMID: 29784039]
Immunology. 2022 May;166(1):2-16 [PMID: 35146757]
Exp Ther Med. 2018 Oct;16(4):3345-3352 [PMID: 30250521]
Dermatology. 2000;200(4):314-6 [PMID: 10894962]
Int J Biol Macromol. 2020 Jun 15;153:317-326 [PMID: 32126204]
Int J Mol Sci. 2021 Jul 08;22(14): [PMID: 34298981]
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592 [PMID: 36300620]
Biomed Res Int. 2015;2015:654765 [PMID: 26697491]
Front Immunol. 2019 Aug 16;10:1867 [PMID: 31474979]
Mol Med Rep. 2021 Feb;23(2): [PMID: 33313947]
J Biol Chem. 2012 Jul 27;287(31):25954-63 [PMID: 22692211]
Int J Mol Sci. 2022 Dec 21;24(1): [PMID: 36613589]
Postepy Dermatol Alergol. 2017 Apr;34(2):126-130 [PMID: 28507491]
Immunol Res. 2020 Oct;68(5):296-309 [PMID: 32827097]
Allergy Asthma Immunol Res. 2021 May;13(3):450-467 [PMID: 33733639]
Nat Protoc. 2012 Apr 05;7(5):850-8 [PMID: 22481530]
Sensors (Basel). 2020 Mar 09;20(5): [PMID: 32182928]
J Immunol. 2015 Sep 1;195(5):2006-18 [PMID: 26223654]
PLoS One. 2017 Jul 10;12(7):e0180853 [PMID: 28700632]
ACS Biomater Sci Eng. 2022 Apr 11;8(4):1494-1505 [PMID: 35230824]
Sci Rep. 2015 Dec 07;5:17776 [PMID: 26640124]
Int J Mol Med. 2011 Nov;28(5):785-92 [PMID: 21805023]
Biochem Biophys Res Commun. 2011 Jul 22;411(1):168-74 [PMID: 21723264]
Front Immunol. 2018 Nov 30;9:2786 [PMID: 30555471]
J Biol Chem. 2022 Jun;298(6):102030 [PMID: 35577075]
Cells. 2022 Sep 13;11(18): [PMID: 36139422]
J Immunol. 2000 Oct 15;165(8):4742-7 [PMID: 11035119]
Cell. 2007 Jun 29;129(7):1261-74 [PMID: 17604717]
Protein Sci. 2019 Nov;28(11):1947-1951 [PMID: 31441146]
Nanotechnology. 2018 Aug 17;29(33):335301 [PMID: 29808832]
Lab Invest. 2012 Dec;92(12):1712-25 [PMID: 23007134]
Immunity. 2013 Dec 12;39(6):1171-81 [PMID: 24332034]
Adv Mater. 2014 Jul 9;26(26):4431-7 [PMID: 24737390]
J Toxicol Pathol. 2013;26(3 Suppl):27S-57S [PMID: 25035577]
Acta Derm Venereol. 1994 Sep;74(5):344-6 [PMID: 7817667]
Biomaterials. 2003 Aug;24(18):3079-85 [PMID: 12895580]
Macromol Biosci. 2010 Jun 11;10(6):664-73 [PMID: 20301120]
Front Immunol. 2022 Jul 07;13:921408 [PMID: 35874668]
Mol Cell Proteomics. 2005 Sep;4(9):1265-72 [PMID: 15958392]
J Eur Acad Dermatol Venereol. 2008 Apr;22(4):451-5 [PMID: 18070018]
Int J Mol Sci. 2010 May 20;11(5):2200-11 [PMID: 20559510]
Int J Mol Sci. 2022 Feb 01;23(3): [PMID: 35163615]
Adv Wound Care (New Rochelle). 2019 Sep 1;8(9):452-462 [PMID: 31737425]
J Am Acad Dermatol. 1995 Apr;32(4):618-22 [PMID: 7534777]
J Drugs Dermatol. 2022 Feb 1;21(2):156-161 [PMID: 35133104]
J Sci Food Agric. 2015 Feb;95(3):635-42 [PMID: 25048579]
Acta Derm Venereol. 1999 Jan;79(1):4-8 [PMID: 10086849]

MeSH Term

Rats
Animals
Sericins
Interleukin-17
Tumor Necrosis Factor-alpha
Fibroins
Psoriasis
Skin
Inflammation
Anti-Inflammatory Agents
TOR Serine-Threonine Kinases
Polymers
Keratinocytes

Chemicals

Sericins
Interleukin-17
Tumor Necrosis Factor-alpha
Fibroins
Anti-Inflammatory Agents
TOR Serine-Threonine Kinases
Polymers
mTOR protein, rat

Word Cloud

Similar Articles

Cited By